Drug shortage
Extended Release · Teva Pharmaceuticals USA, Inc.
FDA drug shortage · To Be Discontinued · updated Jan 23, 2025
Key facts
| Generic name | Extended Release, Verapamil Hydrochloride Capsule |
|---|---|
| Company | Teva Pharmaceuticals USA, Inc. |
| Presentation | Verelan, Capsule, Extended Release, 180 mg (NDC 0591-2882-01) |
| Dosage form | Capsule, Extended Release |
| Status | To Be Discontinued |
| Therapeutic category | Cardiovascular |
| Package NDCs | 0591-2882-01 |
| First posted | Jan 23, 2025 |
| Last updated | Jan 23, 2025 |
| Discontinued | Jan 23, 2025 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: